SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INCR -- Incara Pharmaceuticals
INCR 1.140-5.0%Dec 24 12:55 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject12/17/2003 9:30:07 AM
From: tom pope  Read Replies (1) of 196
 
For those who still have INCR in their portfolios(?)
(I still do, but won't as soon as I finish tax selling - nice to be able to say that, after 2002)

RESEARCH TRIANGLE PARK, N.C., Dec. 17 /PRNewswire-FirstCall/ -- Incara Pharmaceuticals Corporation ( www.incara.com ) announced today that as a result of its recent corporate reorganization, NASDAQ has changed its stock trading symbol to ICRA. In November 2003, Incara completed a corporate reorganization that consisted of the merger of Incara Pharmaceuticals into one of its wholly owned subsidiaries. Incara common stock was converted into common stock of the merged company. The common stock will continue to trade as Incara Pharmaceuticals Corporation on the OTC Bulletin Board with the symbol changed to ICRA, effective today.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext